(Q44628119)

4 December 2017

title

Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts (English)

1 reference

4 December 2017

1 reference

1 reference

Scott A Celinski

1

1 reference

4 December 2017

William E Fisher

2

1 reference

4 December 2017

Felipe Amaya

3

1 reference

4 December 2017

Yuan Qing Wu

4

1 reference

4 December 2017

Q Yao

5

1 reference

4 December 2017

Keith A Youker

6

1 reference

4 December 2017

Min Li

7

1 reference

4 December 2017

publication date

1 November 2003

1 reference

Journal of Surgical Research

4 December 2017

published in

1 reference

4 December 2017

volume

115

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

41-47

1 reference

4 December 2017

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Membrane receptors for peptides in experimental and human pancreatic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Evaluation of receptors for somatostatin in various tumors using different analogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (luteinizing hormone-releasing hormone). The French Associations for Surgical Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

High throughput method for creating and screening recombinant adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

C-Terminal Region of Human Somatostatin Receptor 5 Is Required for Induction of Rb and G1 Cell Cycle Arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Somatostatin receptor subtype 2 gene therapy inhibits pancreatic cancer in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

Transcription of SST2 somatostatin receptor gene in human pancreatic cancer cells is altered by single nucleotide promoter polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-4804%2803%2900276-2

10.1016/S0022-4804(03)00276-2

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference